JPD newsletter banner
 

Volume 8, Issue 2 / 2018 Available Online

Reviews
Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s DiseaseOpen Access
Curry, Daniel W. | Stutz, Bernardo | Andrews, Zane B. | Elsworth, John D.

Progression of Cognitive Decline in Parkinson’s DiseaseOpen Access
Roheger, Mandy | Kalbe, Elke | Liepelt-Scarfone, Inga

Gene Therapy for Parkinson’s Disease, An UpdateOpen Access
Axelsen, Tobias M. | Woldbye, David P.D.

Research Articles
Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson’s Disease Patients? A Systematic Review
Katsaiti, Irene | Nixon, John

Cognitive Rehabilitation in Parkinson’s Disease: A Systematic Review
Alzahrani, Hamad | Venneri, Annalena

What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc AnalysisOpenly Available
Athauda, Dilan | Maclagan, Kate | Budnik, Natalia | Zampedri, Luca | Hibbert, Steve | Skene, Simon S. | Chowdhury, Kashfia | Aviles-Olmos, Iciar | Limousin, Patricia | Foltynie, Thomas

High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease
Hogg, Elliot | Athreya, Kishore | Basile, Christina | Tan, Echo E. | Kaminski, Jan | Tagliati, Michele

Impact of Subthalamic Deep Brain Stimulation Frequency on Upper Limb Motor Function in Parkinson’s DiseaseOpen Access
Momin, Sheikh | Mahlknecht, Philipp | Georgiev, Dejan | Foltynie, Thomas | Zrinzo, Ludvic | Hariz, Marwan | Zacharia, Andre | Limousin, Patricia

Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsOpen Access
Polinski, Nicole K. | Volpicelli-Daley, Laura A. | Sortwell, Caryl E. | Luk, Kelvin C. | Cremades, Nunilo | Gottler, Lindsey M. | Froula, Jessica | Duffy, Megan F. | Lee, Virginia M.Y. | Martinez, Terina N. | Dave, Kuldip D.

Rode balk JPD mailing
JPD 11

Indexed in: PubMed/MEDLINE Scopus

Submit to JPD

Median time to first decision is 3 days!

As a member of our research community, we invite you to contribute your own articles JPD. The journal has a quick turnaround of manuscripts, with a median time to first decision of just 3 days (average is 15 days). JPD offers contributing authors many benefits, including rigorous peer review and speedy manuscript processing, rapid online publication (pre-press) and an Open Access option.

Submit your manuscript online via MsTracker
View detailed Instructions to Authors
Aims and Scope

Rode balk JPD mailing

Most Read JPD Articles in May 2018

Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsOpen Access (Review Article in Vol.8, Iss.2, 2018; was available in pre-press)
Polinski, Nicole K. | Volpicelli-Daley, Laura A. | Sortwell, Caryl E. | Luk, Kelvin C. | Cremades, Nunilo | Gottler, Lindsey M. | Froula, Jessica | Duffy, Megan F. | Lee, Virginia M. Y. | Martinez, Terina N. | Dave, Kuldip D.

Gene Therapy for Parkinson’s Disease, An UpdateOpen Access (Review Article in Vol.8, Iss.2, 2018; was available in pre-press)
Axelsen, Tobias M. | Woldbye, David P.D.

Provoking Freezing of Gait in Clinical Practice: Turning in Place is More Effective than Stepping in PlaceOpen Access (Letter in Vol.8, Iss.2, 2018; was available in pre-press)
van Dijsseldonk, Karlijn | Wang, Ying | van Wezel, Richard | Bloem, Bastiaan R. | Nonnekes, Jorik

Glucocerebrosidase Mutations in Parkinson DiseaseOpen Access (Review Article in Vol.7, Iss.3, 2017)
O’Regan, Grace | deSouza, Ruth-Mary | Balestrino, Roberta | Schapira, Anthony H.

Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodiesOpen Access (Research Article in Vol.6, Iss.3, 2016)
Pagan, Fernando | Hebron, Michaeline | Valadez, Ellen H. | Torres-Yaghi, Yasar | Huang, Xu | Mills, Reversa R. | Wilmarth, Barbara M. | Howard, Hellen | Dunn, Connell | Carlson, Alexis | Lawler, Abigail | Rogers, Sean L. | Falconer, Ramsey A. | Ahn, Jaeil | Li, Zhaoxia | Moussa, Charbel

Rode balk JPD mailing

Launch of Quarterly Collection of Parkinson's Webinars

Delivered by JPD, Parkinson's Movement & CPT

As we announced in our mailing back in April (see here), we are pleased to be working in partnership with The Cure Parkinson’s Trust (CPT) to provide information about breaking research news to be featured on the new web portal for people with Parkinson’s (PwPs) called Parkinson’s Movement: parkinsonsmovement.com. One section of the site is dedicated to sifting through recent research in order to concisely capture a snapshot of the science and translate it to deliver better understanding for all.

Assessing the impact of published PD-related research is done through a panel of experts, researchers and PwPs.The JPD scientific panel consists of JPD Editor-in-Chief Patrik Brundin and a number of members of the JPD Editorial Board. Linked to this initiative, a new series of Quarterly Parkinson's Webinars is to be launched – read more in our news item here.

Inaugural Parkinson Webinar: June 19, 2018
This quarterly webinar series will bring the discussion of specific research topics into the open; the whole process of rating research will become even more transparent.

The inaugural webinar will take place on June 19 in London, UK (5.30 pm BST, 12.30 pm EST) and the topic for discussion will be: “Does exenatide reduce non-motor symptoms in Parkinson’s disease?” The focus of the discussion will be a recent JPD article focusing on exenatide. The webinar will be chaired by Professor Patrik Brundin and joined by fellow panellists: Tom Foltynie from UCL in London, who let the exenatide trial; Nigel Greig and Dimitrios Kapogiannis from the NIA (National Institute on Aging); and exenatide trial participant Penny Kustow. Click the banner (below) to book your place or go here.

Rode balk JPD mailing
Benjamin small

Welcome to JPD's Newest Blog Contributor!

Introducing Benjamin Stecher

We are pleased to introduce Benjamin Stecher, our new JPD blog contributor. Benjamin was diagnosed with Parkinson's disease at 29 and is now actively involved in PD research advocacy as the founder of Tomorrow Edition, co-founder of the Parkinson's Research Advocacy Group, and patient advisor to the World Parkinson's Congress.

Benjamin will contribute unique blog posts to the JPD site, and we also have a new section of the blog called Tomorrow Edition Extracts. To read more about Benjamin, view his biography here and read his first JPD blog post here!

Rode balk JPD mailing
 
 
Powered by Mad Mimi®A GoDaddy® company